Caitong International Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9K Buy
283
+101
+55% +$9.63K 0.01% 913
2025
Q4
$14.8K Buy
182
+154
+550% +$13.3K ﹤0.01% 1059
2025
Q3
$2.45K Buy
+28
New +$2.5K ﹤0.01% 1355
2025
Q1
Sell
-59
Closed -$5.44K 2377
2024
Q4
$5.44K Buy
+59
New +$5.67K 0.01% 1034

Other funds holding LMAT

Caitong International Asset Management's LMAT Position: Q1 2026 in Review

Caitong International Asset Management increased its LeMaitre Vascular (LMAT) stake by 55% in Q1 2026, buying an estimated $9.63K and bringing the position to 283 shares worth $30.9K. The position accounts for 0.01% of the portfolio, ranked #913.

Caitong International Asset Management first reported a position in LMAT in Q4 2024 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Caitong International Asset Management held 283 shares of LeMaitre Vascular worth $30.9K as of Q1 2026.
  • Caitong International Asset Management bought 101 LeMaitre Vascular shares in Q1 2026, an estimated $9.63K.
  • LeMaitre Vascular made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #913 holding.
  • Caitong International Asset Management first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 4 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.